Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX was delisted on the 22nd of January, 2024.
26 hedge funds and large institutions have $141M invested in Mirati Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and closing their positions.
73% more funds holding
Funds holding: 15 → 26 (+11)
53% more capital invested
Capital invested by funds: $92.1M → $141M (+$48.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.5M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$11.1M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$6.84M |
| 4 |
First Eagle Investment Management
New York
|
+$6.62M |
| 5 |
BC
Broadfin Capital
New York
|
+$3.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$7.03M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.15M |
| 3 |
QF
QVT Financial
New York
|
-$889K |
| 4 |
B
Bailard
Foster City,
California
|
-$581K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$137K |
MRTX Hedge Fund Activity: Q4 2013 in Review
26 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q4 2013, worth a combined $141M — up 53% from $92.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MRTX positions and 0 closed out — a net gain of 11 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $12.5M. The largest seller was BVF Inc, cutting an estimated $7.03M.
- 26 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q4 2013, up from 15 in Q3 2013.
- Funds reported $141M of Mirati Therapeutics, Inc. Common Stock stock for Q4 2013, up 53% quarter-over-quarter.
- 11 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q4 2013 and 0 closed out, a net change of +11 holders.
- The largest Mirati Therapeutics, Inc. Common Stock buyer in Q4 2013 was Fidelity Investments, an estimated $12.5M added.
- The largest Mirati Therapeutics, Inc. Common Stock seller in Q4 2013 was BVF Inc, an estimated $7.03M sold.
Based on aggregated 13F filings for Q4 2013.